A detailed history of First Trust Advisors LP transactions in Dexcom Inc stock. As of the latest transaction made, First Trust Advisors LP holds 451,145 shares of DXCM stock, worth $36.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
451,145
Previous 461,027 2.14%
Holding current value
$36.2 Million
Previous $52.3 Million 42.16%
% of portfolio
0.03%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$64.0 - $116.06 $632,448 - $1.15 Million
-9,882 Reduced 2.14%
451,145 $30.2 Million
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $10.6 Million - $13.5 Million
96,382 Added 26.43%
461,027 $52.3 Million
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $12.9 Million - $15.8 Million
112,724 Added 44.75%
364,645 $50.6 Million
Q4 2023

Feb 13, 2024

SELL
$75.49 - $124.16 $20.7 Million - $34.1 Million
-274,863 Reduced 52.18%
251,921 $31.3 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $14.8 Million - $23.7 Million
171,927 Added 48.45%
526,784 $49.1 Million
Q2 2023

Aug 14, 2023

SELL
$112.47 - $130.98 $14.8 Million - $17.2 Million
-131,581 Reduced 27.05%
354,857 $45.6 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $34.8 Million - $41.1 Million
334,657 Added 220.49%
486,438 $56.5 Million
Q4 2022

Feb 09, 2023

SELL
$84.98 - $122.67 $2.38 Million - $3.44 Million
-28,051 Reduced 15.6%
151,781 $17.2 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $15.6 Million - $19.3 Million
-204,502 Reduced 53.21%
179,832 $14.5 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $21 Million - $41 Million
308,522 Added 406.96%
384,334 $28.6 Million
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $3.8 Million - $5.26 Million
-40,395 Reduced 34.76%
75,812 $38.8 Million
Q4 2021

Feb 08, 2022

BUY
$129.87 - $162.82 $6.39 Million - $8.02 Million
49,238 Added 73.52%
116,207 $62.4 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $2.97 Million - $3.99 Million
27,838 Added 71.14%
66,969 $36.6 Million
Q2 2021

Oct 12, 2021

SELL
$80.99 - $107.93 $85,282 - $113,650
-1,053 Reduced 2.62%
39,131 $16.6 Million
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $797,832 - $1.06 Million
-9,851 Reduced 19.69%
40,184 $17.2 Million
Q1 2021

May 14, 2021

SELL
$84.79 - $104.74 $4.01 Million - $4.95 Million
-47,260 Reduced 48.57%
50,035 $18 Million
Q4 2020

Feb 02, 2021

SELL
$78.0 - $104.5 $2.07 Million - $2.78 Million
-26,568 Reduced 21.45%
97,295 $36 Million
Q3 2020

Nov 05, 2020

SELL
$95.51 - $112.95 $3.59 Million - $4.25 Million
-37,626 Reduced 23.3%
123,863 $51.1 Million
Q2 2020

Jul 22, 2020

SELL
$62.68 - $105.34 $5.27 Million - $8.85 Million
-84,012 Reduced 34.22%
161,489 $65.5 Million
Q1 2020

May 06, 2020

BUY
$47.79 - $75.63 $3.57 Million - $5.65 Million
74,729 Added 43.76%
245,501 $66.1 Million
Q4 2019

Feb 03, 2020

SELL
$36.62 - $57.29 $3.97 Million - $6.21 Million
-108,349 Reduced 38.82%
170,772 $37.4 Million
Q3 2019

Nov 04, 2019

BUY
$35.53 - $43.8 $7.75 Million - $9.56 Million
218,188 Added 358.08%
279,121 $41.7 Million
Q2 2019

Jul 30, 2019

SELL
$27.84 - $38.92 $9.63 Million - $13.5 Million
-345,796 Reduced 85.02%
60,933 $9.13 Million
Q1 2019

May 09, 2019

SELL
$28.07 - $38.18 $486,874 - $662,232
-17,345 Reduced 4.09%
406,729 $48.4 Million
Q4 2018

Feb 07, 2019

BUY
$26.99 - $37.37 $3.8 Million - $5.27 Million
140,942 Added 49.78%
424,074 $50.8 Million
Q3 2018

Oct 25, 2018

BUY
$23.35 - $36.72 $1.48 Million - $2.33 Million
63,431 Added 28.87%
283,132 $40.5 Million
Q2 2018

Aug 02, 2018

BUY
$17.54 - $25.22 $2.24 Million - $3.23 Million
127,915 Added 139.36%
219,701 $20.9 Million
Q1 2018

Apr 23, 2018

BUY
$13.06 - $18.54 $1.2 Million - $1.7 Million
91,786 New
91,786 $6.81 Million
Q4 2017

Feb 08, 2018

SELL
$11.12 - $15.38 $105,829 - $146,371
-9,517 Closed
0 $0
Q3 2017

Oct 24, 2017

BUY
$11.36 - $18.98 $108,113 - $180,632
9,517
9,517 $466,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.